# Cryolife (AORT): value investors who own it | moatshark

1 value investor held Cryolife in their Q3 2026 13F, led by First Eagle Investment Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| First Eagle Investment Management | 0.0% | $7.8m | Added +11% | 19 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-10 | GREEN ANDREW M | SVP, Regulatory and Quality | Sold | 11480 | $287k |
| 2026-09-03 | GREEN ANDREW M | SVP, Regulatory and Quality | Sold | 1493 | $39k |
| 2026-09-02 | GREEN ANDREW M | SVP, Regulatory and Quality | Sold | 6510 | $177k |
| 2026-08-19 | Mackin James P | President & CEO | Sold | 70000 | $2.0m |
| 2026-08-14 | Berry Lance A | EVP, COO, CFO & Treasurer | Sold | 715 | $20k |
| 2026-08-14 | GREEN ANDREW M | SVP, Regulatory and Quality | Sold | 616 | $18k |
| 2026-08-12 | Holloway Jean F | SVP, General Counsel | Sold | 977 | $28k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/aort). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.